BG105340A - Карбаматни и карбамидни състави и невротрофични приложения - Google Patents
Карбаматни и карбамидни състави и невротрофични приложенияInfo
- Publication number
- BG105340A BG105340A BG105340A BG10534001A BG105340A BG 105340 A BG105340 A BG 105340A BG 105340 A BG105340 A BG 105340A BG 10534001 A BG10534001 A BG 10534001A BG 105340 A BG105340 A BG 105340A
- Authority
- BG
- Bulgaria
- Prior art keywords
- neurotrophic
- carbamate
- urea compositions
- compositions
- urea
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Изобретението се отнася до фармацевтични състави и до методи за въздействие върху невронна активност. Използват се карбамати и карбамиди с малки молекули, с ниско молекулно тегло и с афинитет към FKBP-тип имунофилини.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/139,672 US6242468B1 (en) | 1997-02-27 | 1998-08-25 | Carbamate and urea compositions and neurotrophic uses |
PCT/US1999/019261 WO2000010553A2 (en) | 1998-08-25 | 1999-08-24 | Carbamate and urea compositions and neurotrophic uses |
Publications (1)
Publication Number | Publication Date |
---|---|
BG105340A true BG105340A (bg) | 2001-12-29 |
Family
ID=22487769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG105340A BG105340A (bg) | 1998-08-25 | 2001-03-14 | Карбаматни и карбамидни състави и невротрофични приложения |
Country Status (18)
Country | Link |
---|---|
US (1) | US6242468B1 (bg) |
EP (1) | EP1107757A2 (bg) |
JP (1) | JP2002523367A (bg) |
KR (1) | KR20010072992A (bg) |
CN (1) | CN1313767A (bg) |
AU (1) | AU5687999A (bg) |
BG (1) | BG105340A (bg) |
BR (1) | BR9912988A (bg) |
CA (1) | CA2341530A1 (bg) |
CZ (1) | CZ2001274A3 (bg) |
EA (1) | EA200100271A1 (bg) |
HU (1) | HUP0103166A3 (bg) |
IL (1) | IL140958A0 (bg) |
MX (1) | MXPA01001937A (bg) |
NO (1) | NO20010946L (bg) |
PL (1) | PL346759A1 (bg) |
SK (1) | SK2562001A3 (bg) |
WO (1) | WO2000010553A2 (bg) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7008960B1 (en) | 1999-03-02 | 2006-03-07 | Vitreo-Retinal Technologies, Inc. | Agents for intravitreal administration to treat or prevent disorders of the eye |
EP1196386A2 (en) * | 1999-07-06 | 2002-04-17 | Vertex Pharmaceuticals Incorporated | N-substituted glycine derivatives |
US20030199574A1 (en) | 2000-03-02 | 2003-10-23 | Vitreo-Retinal Technologies, Inc. | Treatment of ophthalmic disorders using urea and urea derivatives |
US7977385B2 (en) * | 2000-03-02 | 2011-07-12 | Numoda Biotechnologies, Inc. | Agents for corneal or intrastromal administration to treat or prevent disorders of the eye |
US20050137124A1 (en) * | 2002-08-09 | 2005-06-23 | Vitreo-Retinal Technologies, Inc. A California Corporation | Agents for intravitreal administration to treat or prevent disorders of the eye |
EP1402888A1 (en) * | 2002-09-18 | 2004-03-31 | Jerini AG | The use of substituted carbocyclic compounds as rotamases inhibitors |
CN1934117A (zh) | 2004-03-02 | 2007-03-21 | 惠氏公司 | 大环内酯及其生产方法 |
JP2007526312A (ja) * | 2004-03-02 | 2007-09-13 | ワイス | 神経保護および/または神経再生剤としての非免疫抑制性イムノフィリンリガンド |
WO2007061554A2 (en) * | 2005-10-21 | 2007-05-31 | Purdue Research Foundation | Dosage of 4-aminopyridine derivatives for treatment of central nervous system injuries |
WO2013100566A1 (en) * | 2011-12-27 | 2013-07-04 | Bio-Pharm Solutions Co., Ltd. | Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI874163A (fi) | 1986-09-26 | 1988-03-27 | Mitsui Toatsu Chemicals | Katekolderivat samt preparat innehaollande desamma foer haemmande och botande av regressiva sjukdomar i det centrala nervsystemet. |
US5214034A (en) | 1986-09-26 | 1993-05-25 | Mitsui Toatsu Chemicals, Incorporated | Catechol derivatives, and preventive and remedial preparations for regressive disorders in the central nervous system containing the same |
IT1206078B (it) | 1987-06-03 | 1989-04-14 | Polifarma Spa | Procedimento per la produzione di acido 3-indolpiruvico e suoi derivati loro uso farmaceutico |
US5232923A (en) | 1988-03-18 | 1993-08-03 | Mitsui Toatsu Chemicals, Incorporated | Catechol derivatives and pharmaceutical preparations containing same |
US5166317A (en) | 1988-10-31 | 1992-11-24 | Houston Biotechnology Incorporated | Neurotrophic factor |
US5215969A (en) | 1989-08-11 | 1993-06-01 | Hahnemann University | Dopaminergic neurotrophic factor for treatment of Parkinson's disease |
US5620971A (en) | 1991-05-09 | 1997-04-15 | Vertex Pharmaceuticals Incorporated | Biologically active acylated amino acid derivatives |
US5744485A (en) | 1994-03-25 | 1998-04-28 | Vertex Pharmaceuticals Incorporated | Carbamates and ureas as modifiers of multi-drug resistance |
IL115685A (en) * | 1994-11-16 | 2000-08-31 | Vertex Pharma | Amino acid derivatives pharmaceutical compositions containing the same and processes for the preparation thereof |
US6037370A (en) | 1995-06-08 | 2000-03-14 | Vertex Pharmaceuticals Incorporated | Methods and compositions for stimulating neurite growth |
US5717092A (en) | 1996-03-29 | 1998-02-10 | Vertex Pharmaceuticals Inc. | Compounds with improved multi-drug resistance activity |
US5811434A (en) | 1996-11-13 | 1998-09-22 | Vertex Pharmacueticals Incorporated | Methods and compositions for stimulating neurite growth |
US5840736A (en) | 1996-11-13 | 1998-11-24 | Vertex Pharmaceuticals Incorporated | Methods and compositions for stimulating neurite growth |
US5780484A (en) | 1996-11-13 | 1998-07-14 | Vertex Pharmaceuticals Incorporated | Methods for stimulating neurite growth with piperidine compounds |
US5935989A (en) * | 1996-12-31 | 1999-08-10 | Gpi Nil Holdings Inc. | N-linked ureas and carbamates of heterocyclic thioesters |
ZA98825B (en) * | 1997-02-27 | 1998-10-19 | Guilford Pharm Inc | Method of using neurotrophic carbamates and ureas |
-
1998
- 1998-08-25 US US09/139,672 patent/US6242468B1/en not_active Expired - Fee Related
-
1999
- 1999-08-24 CZ CZ2001274A patent/CZ2001274A3/cs unknown
- 1999-08-24 HU HU0103166A patent/HUP0103166A3/hu unknown
- 1999-08-24 AU AU56879/99A patent/AU5687999A/en not_active Abandoned
- 1999-08-24 CN CN99810011A patent/CN1313767A/zh active Pending
- 1999-08-24 EP EP99943869A patent/EP1107757A2/en not_active Withdrawn
- 1999-08-24 JP JP2000565875A patent/JP2002523367A/ja active Pending
- 1999-08-24 IL IL14095899A patent/IL140958A0/xx unknown
- 1999-08-24 PL PL99346759A patent/PL346759A1/xx unknown
- 1999-08-24 MX MXPA01001937A patent/MXPA01001937A/es not_active IP Right Cessation
- 1999-08-24 EA EA200100271A patent/EA200100271A1/ru unknown
- 1999-08-24 SK SK256-2001A patent/SK2562001A3/sk unknown
- 1999-08-24 CA CA002341530A patent/CA2341530A1/en not_active Abandoned
- 1999-08-24 WO PCT/US1999/019261 patent/WO2000010553A2/en not_active Application Discontinuation
- 1999-08-24 BR BR9912988-4A patent/BR9912988A/pt not_active IP Right Cessation
- 1999-08-24 KR KR1020017002444A patent/KR20010072992A/ko not_active Application Discontinuation
-
2001
- 2001-02-23 NO NO20010946A patent/NO20010946L/no not_active Application Discontinuation
- 2001-03-14 BG BG105340A patent/BG105340A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
CZ2001274A3 (cs) | 2001-09-12 |
SK2562001A3 (en) | 2001-09-11 |
WO2000010553A3 (en) | 2000-05-18 |
IL140958A0 (en) | 2002-02-10 |
BR9912988A (pt) | 2001-10-02 |
NO20010946D0 (no) | 2001-02-23 |
HUP0103166A2 (hu) | 2002-05-29 |
NO20010946L (no) | 2001-02-23 |
KR20010072992A (ko) | 2001-07-31 |
AU5687999A (en) | 2000-03-14 |
PL346759A1 (en) | 2002-02-25 |
CA2341530A1 (en) | 2000-03-02 |
WO2000010553A2 (en) | 2000-03-02 |
MXPA01001937A (es) | 2002-04-24 |
US6242468B1 (en) | 2001-06-05 |
EP1107757A2 (en) | 2001-06-20 |
EA200100271A1 (ru) | 2001-10-22 |
JP2002523367A (ja) | 2002-07-30 |
HUP0103166A3 (en) | 2002-10-28 |
CN1313767A (zh) | 2001-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2248110A1 (en) | (hydroxyalkyl)urea crosslinking agents | |
DK0960107T3 (da) | 6-Thiosubstituerede paclitaxeler | |
DK1091975T3 (da) | Ny cyclosporin med forbedret aktivitetsprofil | |
DE69739163D1 (de) | Molekül, welches Genotyp und Phänotyp zusammenführt und dessen Anwendungen | |
BR9916896A (pt) | Diaril aminas substituìdas com 1-heterociclo | |
ID23374A (id) | Halogenopirimidin | |
HK1054746A1 (en) | Hexahydrofuro'2,3-B!furan-3-yl-N- Ä3'(1,3-benzodioxol -5- ylsulfonyl) (isobutyl) amino! -1-benzyl-2-hydroxypropylÜ carbamate as retroviral protease inhibitor. | |
DE59003133D1 (de) | Lenkrolle für verfahrbare Arbeitsbühnen, Gerüste od.dgl. | |
MA26846A1 (fr) | Derives de 2,4-diaminopyrimidine utiles comme agents immunosuppresseurs. | |
BG105340A (bg) | Карбаматни и карбамидни състави и невротрофични приложения | |
DE69411271D1 (de) | N-alkylthiopolyaminderivate als radioprotektive mittel | |
HUP0102671A3 (en) | Immunosupressive pharmaceutical compositions containing 2',2'-difluoro-nucleoside analogues | |
WO2002067865A3 (en) | N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof | |
DE69816059D1 (de) | Gen, das für das pyruvat dehydrogenase kinase von pflanzen kodiert | |
WO1998027058A3 (en) | N-piperazin-1-ylphenyl-benzamide derivatives | |
WO1999037291A3 (de) | Verwendung von substituierten sulfonamiden als antivirale mittel und neue stoffe | |
CA2205868A1 (en) | Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them | |
WO1999043285A3 (en) | Sulphonamide derivatives | |
ZA966885B (en) | Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors. | |
DE69818492D1 (en) | 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele | |
ATE234816T1 (de) | Von azacycloalkanen abgeleitete urethane, ihre thio- und dithioanaloga, deren herstellung und deren verwendung als 2,3-epoxisqualen-lanosterol- cyclase inhibitoren | |
MXPA04005226A (es) | 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion. | |
HUP0200089A3 (en) | Carbamate derivatives of diaryl 1,3,4-oxadiazolone | |
ZA9710581B (en) | Process for making 2-amino-2-imidazoline, guanidine and 2-amino-3,4,5,6-tetrahydropyrimidine derivates. | |
ZA971022B (en) | N-(3,3-dimethylbutyl)-l-aspartyl-d-alpha-aminoalkanyoic acid n-(s)- 1-phenyl-1-alkanamide useful as a sweeting agent. |